Medication Dosing for 62-Year-Old Female (55 kg) Undergoing Pedicular C-Arm Guided Biopsy
For this 62-year-old, 55 kg patient at high risk for renal toxicity, avoid ketorolac entirely and use tramadol with extreme caution; sugammadex dosing should be 2 mg/kg (110 mg) for moderate block reversal, and "Antron" cannot be recommended as it is not an identifiable medication.
Critical Patient Risk Factors
This patient has three high-risk characteristics that fundamentally alter medication selection:
- Age >60 years - places her at high risk for NSAID-related renal, GI, and cardiac toxicities 1
- Weight <50 kg threshold - requires dose reduction for multiple agents 2
- Potential renal impairment - age >60 years with compromised fluid status from procedure increases nephrotoxicity risk 1
Ketorolac: AVOID in This Patient
Ketorolac should NOT be used in this patient due to multiple contraindications:
- Age >60 years is explicitly listed as high-risk for renal toxicities with NSAIDs, particularly when combined with compromised fluid status from procedures 1
- NSAIDs are associated with renal dysfunction after surgery, and this patient meets criteria for discontinuation if used 3
- If ketorolac were to be considered despite these risks, the FDA-approved dose for patients ≥65 years OR <50 kg would be 15 mg IV every 6 hours (maximum 60 mg/day) for no more than 5 days, given over at least 15 seconds 2
- However, acetaminophen 1 gram IV every 8 hours is the safest nonopioid analgesic and should be used instead 3
Tramadol: Use With Significant Caution
If tramadol is used, dose conservatively at 50-75 mg IV/PO every 6-8 hours with the following critical warnings:
- Tramadol has a high delirium risk, which is particularly concerning in patients >60 years 3
- Tramadol is NOT recommended in renal insufficiency (GFR <30 mL/min/1.73 m²) and ESRD 4
- Tramadol requires CYP2D6 metabolism to be effective; concomitant medications that inhibit this enzyme will reduce efficacy 4
- Tramadol increases serotonergic/noradrenergic activity, creating drug interaction risks 4
- Despite risks, tramadol produces a 25% decrease in morphine consumption and improved patient comfort postoperatively 3
- The combination of ketorolac plus tramadol shows synergistic effects in pain control, but given this patient's contraindications to ketorolac, this combination cannot be recommended 5, 6, 7
Sugammadex: Standard Dosing
Sugammadex dose: 2 mg/kg (110 mg) IV for moderate block reversal OR 4 mg/kg (220 mg) IV for immediate reversal:
- For reversal at reappearance of T2 (moderate block): 2 mg/kg = 110 mg IV bolus 8
- For immediate reversal (3 minutes after rocuronium): 4 mg/kg = 220 mg IV bolus 8
- No dose adjustment needed for age or weight in this range - the <50 kg threshold mentioned for other medications does not apply to sugammadex 8
- Median time to recovery of T4/T1 ratio to 0.9 is approximately 2 minutes 8
- In renal impairment, sugammadex half-life increases (mild: 4 hours, moderate: 6 hours, severe: 19 hours), but no specific dose adjustment is provided in labeling 8
"Antron": Cannot Be Recommended
"Antron" is not an identifiable medication in standard pharmaceutical references. This may be:
- A transcription error
- A regional/trade name not in common use
- Ondansetron (antiemetic) misheard/misspelled
Do not administer any medication without clear identification and verification.
Recommended Multimodal Approach for This Patient
The optimal pain management strategy avoids ketorolac entirely:
- Acetaminophen 1 gram IV every 8 hours - safest nonopioid option 3
- Low-dose opioids (fentanyl/hydromorphone) as needed - preferred over tramadol due to lower delirium risk 3
- Dexmedetomidine infusion - reduces opioid requirements, lowers delirium incidence, and maintains hemodynamic stability 3
- Pregabalin 75-150 mg PO or Gabapentin 300-600 mg PO preoperatively - reduces opioid requirements 3
Critical Monitoring Requirements
If NSAIDs are used despite contraindications, mandatory monitoring includes: